Loky do
★    

Egypt,
2025-12-04 19:54
(187 d 13:02 ago)

Posting: # 24520
Views: 1,775
 

 Dosing of oral sprinkle granules [Design Issues]

Dears

In a bioequivalence study of deferasirox oral sprinkle granules, the FDA draft guidance recommends conducting both fasted and fed studies. However, the FDA label states that the dose should be administered by sprinkling the granules onto a soft food such as yogurt or applesauce. For the fasted BE study, should the dose still be administered by sprinkling the granules onto a soft food (e.g., yogurt or applesauce), or should it be given differently to comply with fasting conditions?

Thanks in advance
jag009
★★★

NJ,
2026-01-21 19:24
(139 d 13:32 ago)

@ Loky do
Posting: # 24552
Views: 1,087
 

 Dosing of oral sprinkle granules

❝ In a bioequivalence study of deferasirox oral sprinkle granules, the FDA draft guidance recommends […]

This one? Deferasirox
J
Darborn
☆    

Taiwan,
2026-01-22 09:52
(138 d 23:04 ago)

@ Loky do
Posting: # 24553
Views: 1,065
 

 Dosing of oral sprinkle granules

Hi Loky do

In my opinion, a BE study is intended to demonstrate therapeutic equivalence under the SAME connitions as required by the RLD label. If you conduct a BE study with the administration method differing from the RLD label, it seems meaningless. Thus, both fasted and fed conditions should use the sprinkle procedure mentioned in the label.
UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
211 visitors (0 registered, 211 guests [including 22 identified bots]).
Forum time: 09:56 CEST (Europe/Vienna)

In theory, there is no difference between theory and practice.
But, in practice, there is.    Jan L.A. van de Snepscheut

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5